Case-Based Roundtable Meetings Spotlight: January 2023

Piotrowska Looks at Amivantamab and Mobocertinib for Patients With Rare Driver Mutations in NSCLC

January 16, 2023

Clinical Articles

During a Targeted Oncology case-based roundtable event, Zofia Piotrowska, MD, MHS, discussed molecular testing for actionable mutations and recommended treatments for a patient with non–small cell lung cancer and an EGFR exon 20 insertion.

Callander Compares Doublet and Triplet Therapy in Early-Relapse Multiple Myeloma

January 13, 2023

Clinical Articles

During a Targeted Oncology case-based roundtable event, Natalie S. Callander, MD, discussed studies that support alternative combination regimens after early relapse on bortezomib, lenalidomide, and dexamethasone for multiple myeloma.

Vaishampayan Reviews Frontline IO/TKI Regimens for Favorable-Risk ccRCC

January 12, 2023

Clinical Articles

During a Targeted Oncology case-based roundtable event, Ulka N. Vaishampayan, MBBS, discussed the frontline combination regimens available for a patient with favorable risk clear cell renal cell carcinoma.

Brose and Laetsch Discuss Rare Actionable Targets in Patients With Thyroid Cancer

January 12, 2023

Clinical Articles

During a Targeted Oncology case-based roundtable event, Marcia S. Brose, MD, PhD, and Theodore W. Laetsch, MD, discussed the data supporting the use of NTRK inhibitors in a patient with metastatic papillary thyroid cancer.